News from Business Insider Markets

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Crypto Assets Investors Cryptocurrency Shares Stock Stock Market Ethereum Price Markets Xrp Investment Blockchain Sec Etf Stablecoin Eth Trade Earnings Bse Index Ipo Solana Revenue China Coinbase Token Wall Street Nasdaq Inflation Interest Rates Trade War Sensex Usd Economy Tesla Profit Nse Digital Assets Traders Gold Sp 500 Bse Sensex Treasury Federal Reserve Gold Project Ig Group Simona Investment Schemes Global Flows Equity Holders Gqg Classover Drug Trial Canada Pension Plan

Filter by:

Trpv3 Inhibitor × Past year × Business Insider Markets ×

Business Insider Markets • Jun 03, 2025

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...

Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...

Read Full Article →